XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Other Intangible Assets
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block] OTHER INTANGIBLE ASSETS
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)September 30, 2020December 31, 2019September 30, 2019
 GrossAccumulated
Amortization		NetGrossAccumulated
Amortization		NetGrossAccumulated
Amortization		Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm1
$6,265 $(253)$6,012 $6,265 $(63)$6,202 
Customer-related
1,966 (352)1,614 1,977 (268)1,709 $1,969 $(238)$1,731 
Developed technology
1,463 (499)964 1,463 (370)1,093 1,463 (332)1,131 
Trademarks/trade names
161 (86)75 166 (86)80 166 (84)82 
Favorable supply contracts
475 (279)196 475 (207)268 475 (183)292 
Other2
405 (233)172 404 (213)191 401 (206)195 
Total other intangible assets with finite lives
10,735 (1,702)9,033 10,750 (1,207)9,543 4,474 (1,043)3,431 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D
10 — 10 10 — 10 100 — 100 
Germplasm1
6,265 — 6,265 
Tradename
1,871 — 1,871 1,871 — 1,871 1,871 — 1,871 
Total other intangible assets
1,881 — 1,881 1,881 — 1,881 8,236 — 8,236 
Total$12,616 $(1,702)$10,914 $12,631 $(1,207)$11,424 $12,710 $(1,043)$11,667 
1.Beginning on October 1, 2019, the company changed its indefinite life assertion of the germplasm assets to definite lived with a useful life of 25 years.  This change is the result of a more focused development effort of new seed products coupled with an intent to out license select germplasm on a non-exclusive basis. Prior to changing the useful life of the germplasm assets, the company tested the assets for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the assets were not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.


As discussed in Note 5 - Restructuring and Asset Related Charges - Net, during the three months ended September 30, 2019, and in connection with strategic product and portfolio reviews, the company determined that the fair value of certain intangible assets classified as developed technology, other intangible assets and IPR&D within the Seed segment that primarily relate to heritage DAS intangibles previously acquired from Coodetec was less than the carrying value due to the company’s focus on advancing more competitive products and eliminating redundancy and complexity across the breeding programs.

For IPR&D and developed technology, the company concluded these projects were abandoned. For other intangible assets, the company performed an analysis of the fair value using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The key assumptions used in the calculation included projected revenue, royalty
rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset impairment charge of $54 million ($41 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the three and nine months ended September 30, 2019.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $162 million and $501 million for the three and nine months ended September 30, 2020, respectively, and $100 million and $314 million for the three and nine months ended September 30, 2019, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2020 and each of the next five years is approximately $160 million, $644 million, $623 million, $544 million, $530 million and $492 million, respectively.